Mason W. Russell, MAPE, an internationally known health economist with nearly 30 years of industry and consulting experience, has joined RTI Health Solutions (RTI-HS) as Head of Health Economics. He is based in our
Mason brings considerable technical expertise to the interface between health economics, observational research, and market access strategy. He is a specialist in economic evaluation (including cost of illness estimation and cost-effectiveness/cost-utility modeling), global pricing and reimbursement strategy, and observational research design and operations. His work in economic modeling, patient registries, economic evaluations of clinical trials, and commercial strategy has been international in scope, focusing on issues relevant to major markets in North America, Europe, and Australasia.
Previously, he served as Director, Global Commercial Strategy for Biogen Idec, and in senior research management positions for several global health economics consultancies.
Aspects of Mr. Russell’s research have appeared in more than 100 articles and abstracts in peer-reviewed journals, including
Circulation, Journal of Rheumatology, Neurology, and PharmacoEconomics. He is a member of several professional societies, including the International Society for Pharmacoeconomics and Outcomes Research, the American College of Healthcare Executives, and the Honor Society of Phi Kappa Phi. He is a subject of biographical record in
Who’s Who in America, Who’s Who in Medicine and Healthcare, and
Who’s Who in Science and Engineering.
Mason completed all requirements for the PhD in Economics except the dissertation and received the Master of Arts in Political Economy (MAPE) at Boston University, Boston, MA. He also holds a BA in economics from Salem State College, Salem MA.
"I am extremely excited to join such an enthusiastic team of distinguished researchers. Having worked for several competitors as well as in industry, I came to know RTI Health Solutions as a leader in the health economics and outcomes research space. I look forward to contributing to the outstanding reputation of RTI Health Solutions and to serving the needs of our customers in the pharma, biotech, medical device, and diagnostics industries," said Mason.
About RTI Health Solutions
RTI Health Solutions provides scientifically rigorous research and consulting services in health economics, patient-reported outcomes, regulatory and health outcomes strategy, market access, health preference assessment, epidemiology, biostatistics, drug safety and pharmacovigilance, preclinical and clinical development to help biopharmaceutical companies successfully develop and gain market approval for their products.